Immatics (IMTX)
(Delayed Data from NSDQ)
$12.92 USD
+0.57 (4.62%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $12.95 +0.03 (0.23%) 7:10 PM ET
1-Strong Buy of 5 1
F Value F Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IMTX 12.92 +0.57(4.62%)
Will IMTX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for IMTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMTX
Wall Street Analysts Predict a 54.95% Upside in Immatics (IMTX): Here's What You Should Know
Here's Why 'Trend' Investors Would Love Betting on Immatics (IMTX)
IMTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stock Market News for May 15, 2024
Immatics (IMTX) Reports Q1 Loss, Tops Revenue Estimates
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
Other News for IMTX
Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024
Immatics N.V. AGM Concludes Successfully
Tracking Baker Brothers Portfolio - Q1 2024 Update
Immatics N.V. Schedules 2024 Annual Meeting
12 Health Care Stocks Moving In Friday's Intraday Session